tm logo
SURFACE ONCOLOGY
Live/Registered
REGISTERED

on 03 Oct 2023

Last Applicant/ Owned by

50 Hampshire Street

Cambridge

MA

02139

Serial Number

88720992 filed on 10th Dec 2019

Registration Number

7183187 registered on 03rd Oct 2023

in the Principal Register

Correspondent Address

Stacey C. Friends

MORSE

480 TOTTEN POND ROAD, 4TH FLOOR

WALTHAM, MA 02451

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"ONCOLOGY"

SURFACE ONCOLOGY

"ONCOLOGY" The colors bright blue and dark blue are claimed as a feature of the mark. Biological preparations for the treatment of cancer The mark consists of the stylized word "SURFACE"stacked on top of the stylized word "ONCOLOGY". The top half of the word "SURFACE" is a bright blue and the bottom half is a darker blue. The word "ONCOLOGY" is the same darker blue.

Classification Information


Class [005]
Pharmaceutical Products


Biological preparations for the treatment of cancer


First Use Date in General

20th Dec 2022

First Use Date in Commerce

20th Dec 2022

Mark Details


Serial Number

No 88720992

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 10062-33495

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Description of Design Search

The mark consists of the stylized word "SURFACE"stacked on top of the stylized word "ONCOLOGY". The top half of the word "SURFACE" is a bright blue and the bottom half is a darker blue. The word "ONCOLOGY" is the same darker blue.

Legal History


Show more

Status DateAction Taken
03rd Oct 2023REGISTERED-PRINCIPAL REGISTER
03rd Oct 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
29th Aug 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28th Aug 2023SU-EXAMINER'S AMENDMENT WRITTEN
28th Aug 2023EXAMINERS AMENDMENT E-MAILED
28th Aug 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28th Aug 2023EXAMINER'S AMENDMENT ENTERED
28th Aug 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11th May 2023SU - NON-FINAL ACTION - WRITTEN
11th May 2023NON-FINAL ACTION E-MAILED